Valeant Says Allergan Lied To Obstruct $53M Takeover
Valeant Pharmaceuticals International Inc. and hedge fund Pershing Square Capital Management LP on Tuesday filed counterclaims in Allergan Inc.'s insider trading suit, alleging Allergan, the target of a $53 billion hostile...To view the full article, register now.
Already a subscriber? Click here to view full article